# Essential Pharma Limited Company profile · SME (from the award notice) - Legal form: Ltd - Seat: Egham, Surrey, United Kingdom Based on the notices and sources Inteliwert covers; not a complete record. Last checked 1 August 2024. ## Identifiers Not found in the indexed notices. ## Track record in public tenders Awards in the covered notices over the last 36 months, per CPV division. No award found in the indexed notices of the last 36 months. ### Awards - [Abschluss einer nicht-exklusiven Rabattvereinbarung nach § 130a Absatz 8 SGB V zum Wirkstoff Colistin, ATC J01XB01 für die Zeit 01.08.2024 - 31.07.2026](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum) Buyer: DAK-Gesundheit · Awarded: 1 August 2024 · CPV 33600000 ## Certifications and prequalification No certification or prequalification found in the covered sources. A certification missing here is unknown, not absent. ## Website and LinkedIn Not found in the indexed notices. ## Open tenders that might fit *Possible match based on public information* Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances. - [Arzneimittelrabattverträge gem. § 130a Abs. 8 SGB V im Rahmen von Open-House-Verfahren](https://inteliwert.com/tender/opp_SH0FBJ2SDH14XGX076PHVW3DG7/arzneimittelrabattvertraege-gem-130a-abs-8-sgb-v-im-rahmen-von-open-house-verfah) Open · SME (from the award notice) · New to public tenders · Buyer: IKK classic · Deadline: 5 Jul 2028, 23:59 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/90e38bd0-40a2-47b5-b826-d7e01809c1d6), Last checked 8 Nov 2026, 11:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-08-01): [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - [Arzneimittel mit dem Wirkstoff Testosteron (ATC: G03BA03 - in der Darreichungsform Gel)](https://inteliwert.com/tender/opp_Y3JE1HM2W51E4N1BKWCWKE4EBK/arzneimittel-mit-dem-wirkstoff-testosteron-atc-g03ba03-in-der-darreichungsform-g) Open · SME (from the award notice) · New to public tenders · Buyer: AOK Sachsen - Anhalt · Deadline: 31 Jul 2028, 00:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/4d242533-630a-4b44-b613-307f9ff3e20c), Last checked 8 Nov 2026, 15:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-08-01): [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - [Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130 a Abs. 8 SGB V mit dem Wirkstoff ab dem 01.10.2026](https://inteliwert.com/tender/opp_18XHM40HRSJQ233B64FWXANJ1R/abschluss-nicht-exklusiver-rabattvereinbarungen-nach-130-a-abs-8-sgb-v-mit-dem-w) Open · SME (from the award notice) · New to public tenders · Buyer: GWQ ServicePlus AG · Deadline: 10 May 2028, 10:00 (UTC+02:00) · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/f0f0ad06-3f17-412c-9106-71d28765bbb2), Last checked 8 Nov 2026, 09:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-08-01): [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - [Zwei Produktivsysteme für Klinische Chemie und Immunologie Krankenhaus Märkisch-Oderland GmbH](https://inteliwert.com/tender/opp_V8MX4ZN1NKXM6DF09PBWFQRVH5/zwei-produktivsysteme-fuer-klinische-chemie-und-immunologie-krankenhaus-maerkisc) Open · SME (from the award notice) · New to public tenders · Buyer: Krankenhaus Märkisch-Oderland GmbH · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/45ecd609-686a-448c-9ad1-33f4eee77f64), Last checked 8 Nov 2026, 14:31 (UTC+01:00) - Won a contract in CPV group 336 (2024-08-01): [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - [Rahmenvereinbarung über Reagenzienleasing für die immunhämatologische Diagnostik](https://inteliwert.com/tender/opp_C8F68P16TPAHA8TFFWTXRZPJEX/rahmenvereinbarung-ueber-reagenzienleasing-fuer-die-immunhaematologische-diagnos) Open · SME (from the award notice) · New to public tenders · Buyer: Labor Berlin - Charité Vivantes GmbH · [Official notice](https://oeffentlichevergabe.de/ui/de/notices/10c5eb36-82fe-47ce-96ab-7ccfa5e631c2), Last checked 8 Nov 2026, 13:30 (UTC+01:00) - Won a contract in CPV group 336 (2024-08-01): [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 - 1 award in this field in 36 months, from 1 buyer: [Evidence](https://inteliwert.com/tender/opp_DCGWZDD2WAC8W52Y03BEMJG7A8/abschluss-einer-nicht-exklusiven-rabattvereinbarung-nach-130a-absatz-8-sgb-v-zum), checked 8 Nov 2026 ## Is this your company? Send corrections, or ask us to remove the profile, to . You can also ask that the company never be tagged on LinkedIn. ## About this profile Each fact on this page shows its source: a public notice, an open-data register (GLEIF, Wikidata) or the company’s own website. Inteliwert does not rate companies and does not judge eligibility, fit or chances. **Based on the notices and sources Inteliwert covers; not a complete record.** Last checked 1 August 2024. --- Page: https://inteliwert.com/company/org_JRDYWXFGW0WPKB1WJK693692X9/essential-pharma-limited Inteliwert is a product of Bandpey GmbH, an international data and AI software company in Munich, Germany, founded and led by Roozbeh Bandpey. Bandpey's products: Facthory, Emolysis, Copolly and Inteliwert. Inteliwert on LinkedIn: https://www.linkedin.com/company/intelliwert, GitHub: https://github.com/inteliwertai.